Theralase Technologies Inc (TLT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 81 | 46 | 132 | 269 | 330 |
| Receivables | 813 | 801 | 669 | 712 | 622 |
| Inventories | 480 | 531 | 515 | 545 | 610 |
| Other current assets | 125 | 131 | 86 | 58 | 91 |
| TOTAL | $1,500 | $1,509 | $1,402 | $1,584 | $1,652 |
| Non-Current Assets | |||||
| PPE Net | 504 | 555 | 605 | 606 | 667 |
| Other Non-Current Assets | 1,001 | 952 | 952 | 1,057 | 903 |
| TOTAL | $1,505 | $1,507 | $1,557 | $1,663 | $1,570 |
| Total Assets | $3,004 | $3,016 | $2,959 | $3,247 | $3,222 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 100 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,028 | 1,067 | 1,118 | 362 | 337 |
| Accrued Expenses | 564 | 428 | 482 | 523 | 429 |
| TOTAL | $1,799 | $1,573 | $1,702 | $986 | $863 |
| Non-Current Liabilities | |||||
| TOTAL | $113 | $167 | $167 | $194 | $220 |
| Total Liabilities | $1,912 | $1,740 | $1,869 | $1,180 | $1,083 |
| Shareholders' Equity | |||||
| Common Shares | 50,099 | 49,698 | 49,109 | 48,924 | 48,517 |
| Retained earnings | -70,931 | -69,919 | -68,967 | -67,496 | -66,578 |
| Other shareholders' equity | 3,831 | 3,566 | 3,178 | 3,058 | 3,019 |
| TOTAL | $1,093 | $1,276 | $1,090 | $2,067 | $2,139 |
| Total Liabilities And Equity | $3,004 | $3,016 | $2,959 | $3,247 | $3,222 |